4.7 Review

Monogenic autoinflammatory diseases

期刊

RHEUMATOLOGY
卷 53, 期 11, 页码 1927-1939

出版社

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keu170

关键词

autoinflammatory; periodic fevers; familial Mediterranean fever; genetic; biologic agents

资金

  1. Novartis
  2. Rosetrees Trust [M8-F1-CD1] Funding Source: researchfish

向作者/读者索取更多资源

During the past 15 years, a growing number of monogenic inflammatory diseases have been described and their respective responsible genes identified. The proteins encoded by these genes are involved in the regulatory pathways of inflammation and are mostly expressed in cells of the innate immune system. Diagnosis remains clinical, with genetic confirmation where feasible. Although a group of patients exhibit episodic systemic inflammation (periodic fevers), these disorders are mediated by continuous overproduction and release of pro-inflammatory mediators, such as IL-1 and IL-6, and TNF and are best considered as autoinflammatory diseases rather than periodic fevers. Treatment with biologic agents that block these cytokines, particularly IL-1, has proved to be dramatically effective in some patients. Still, in many cases of autoinflammation no genetic abnormalities are detected and treatment remains suboptimal, raising the question of novel pathogenic mutations in unexplored genes and pathways.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据